Together, we've reported 306,352 GLP-1 shortages to the FDA

heroGlobeGraphic

Shortage report

Feb 2 - 8
Updated: 10 days ago
Cumulative
37%
MoM increase in GLP-1
shortage reports
09/01
09/08
09/15
09/22
09/29
10/06
10/13
10/20
10/27
11/03
11/10
11/17
11/24
12/01
12/08
12/15
12/22
12/29
01/05
01/12
01/19
01/26
306,352
02/02
Medications
The majority of shortages are name brand Semaglutide and Tirzepatide
Wegovy® (Semaglutide)
Wegovy® (Semaglutide)
85,645
Ozempic® (Semaglutide)
Ozempic® (Semaglutide)
84,802
Mounjaro® (Tirzepatide)
Mounjaro® (Tirzepatide)
44,818
Unspecified
Unspecified
43,586
Zepbound® (Tirzepatide)
Zepbound® (Tirzepatide)
38,257
Saxenda® or Victoza (Liraglutide)
Saxenda® or Victoza (Liraglutide)
4,753
Trulicity® (Dulaglutide)
Trulicity® (Dulaglutide)
4,491
By state
Florida
22,590+1,348
Texas
21,050+1,163
New York
17,690+900
California
23,654+872
Pennsylvania
14,182+817